Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in adult liver transplantation

被引:34
|
作者
Rayya, F. [1 ]
Harms, J. [1 ]
Martin, A. P. [1 ]
Bartels, M. [1 ]
Hauss, J. [1 ]
Fangmann, J. [1 ]
机构
[1] Univ Leipzig, Clin Visceral Transplantat Thorac & Vasc Surg, Leipzig, Germany
关键词
D O I
10.1016/j.transproceed.2008.03.044
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. A safe and effective preservation solution is a precondition for successful orthotopic liver transplantation (OLT). This study compared University of Wisconsin (UW) and histidine-tryptophan-ketoglutarate (HTK) solutions in OLT. Patients and Methods. We retrospectively reviewed the medical records of 137 primary cadaveric. OLT performed between January 2003 and December 2006 at our institution. Sixty-eight grafts were harvested using UW and 69 using HTK. Recipients were managed similarly in regard to operative techniques and immunosuppression. We collected donor data including serum transaminases, serum sodium, ICU stay and assessed macroscopic liver quality. Recipient serum transaminases were collected on postoperative days 1, 7, 14, and 30. We compared biliary and vascular complications, as well as patient and graft survivals. Results. Mean serum bilirubin levels were slightly higher in the HTK group at 1,7,14, and 30 days after transplantation, whereas transaminases were higher in the UW group. Primary nonfunction occurred in 1 patient in each group. Retransplantation was performed in 5 patients in the UW and in 9 patients in the HTK group. Biliary complication rates were similar in the UW and HTK groups (22% and 17%, respectively). Six arterial complications occurred in the HTK (8.7%) and 2 in the UW group (2.9%; P < .05). Mean follow-up was 25 months. Graft survival at 1, 12, and 36 months was 90%, 78%, and 75% versus 90%, 71%, and 71% in the UW versus HTK groups, respectively. One-, 12-, and 36-month patient survival rates were 93%, 78%, and 75% versus 93%, 78%, and 78% in the UW versus HTK groups, respectively. Conclusions. There were no significant differences in graft and patient survivals between the 2 groups. Whereas the biliary complication rates were comparable in both groups, the arterial complications were clearly higher in the UW group (8.7% vs 2.9%; P < .05%). UW and HTK solutions seemed to be equally safe and effective in the preservation of liver grafts. The high incidence of arterial complications in the UW group requires further prospective studies.
引用
收藏
页码:891 / 894
页数:4
相关论文
共 50 条
  • [1] Comparison of histidine-tryptophan-ketoglutarate solution (HTK) and University of Wisconsin solution (UW) in adult liver transplantation
    Mangus, RS
    Tector, AJ
    Agarwal, A
    Vianna, R
    Murdock, P
    Fridell, JA
    LIVER TRANSPLANTATION, 2006, 12 (02) : 226 - 230
  • [2] Histidine-Tryptophan-Ketoglutarate Solution Versus University of Wisconsin Solution in Cadaveric Liver Transplantation
    Dai, W. C.
    Chan, S. C.
    Chok, K. S.
    Cheung, T. T.
    Chan, A. C. Y.
    Sharr, W. W.
    Fung, Y. Y.
    Wong, T. C.
    TRANSPLANTATION, 2015, 99 : 230 - 230
  • [3] Comparison of histidine-tryptophan-ketoglutarate solution and University of Wisconsin solution in intestinal and multivisceral transplantation
    Mangus, Richard S.
    Tector, A. Joe
    Fridell, Jonathan A.
    Kazimi, Marwan
    Hollinger, Edward
    Vianna, Rodrigo M.
    TRANSPLANTATION, 2008, 86 (02) : 298 - 302
  • [4] Comparison of Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solution in Liver Reperfusion Biopsies
    Moisan, Fabrizio
    Gabrielli, Mauricio
    Varas, Julian
    Vidal, Marcela
    Duarte, Ignacio
    Arrese, Marco
    Benitez, Carlos
    Maria Perez, Rosa
    Francisco Guerra, Juan
    Jarufe, Nicolas
    Martinez, Jorge
    LIVER TRANSPLANTATION, 2011, 17 (06) : S282 - S283
  • [5] COMPARISON OF HISTIDINE-TRYPTOPHAN-KETOGLUTARATE (HTK) SOLUTION AND UNIVERSITY OF WISCONSIN (UW) SOLUTION IN PANCREAS TRANSPLANTATION
    Grzella, S.
    Viebahn, R.
    Schenker, P.
    TRANSPLANT INTERNATIONAL, 2014, 27 : 18 - 18
  • [7] Comparison of histidine-tryptophan-ketoglutarate solution and university of wisconsin solution in extended criteria liver donors
    Mangus, Richard S.
    Fridell, Jonathon A.
    Vianna, Rodrigo M.
    Milgrom, Martin A.
    Chestovich, Paul
    Chihara, Ray K.
    Tector, A. Joseph
    LIVER TRANSPLANTATION, 2008, 14 (03) : 365 - 373
  • [8] Histidine-tryptophan-ketoglutarate solution vs. University of Wisconsin solution for liver transplantation: A systematic review
    Feng, Li
    Zhao, No
    Yao, Xun
    Sun, Xin
    Du, Liang
    Diao, Xiang
    Li, Shengfu
    Li, Youping
    LIVER TRANSPLANTATION, 2007, 13 (08) : 1125 - 1136
  • [9] Comparison of histidine-tryptophan-ketoglutarate solution and university of wisconsin solution for organ preservation in clinical pancreas transplantation
    Fridell, JA
    Agarwal, A
    Milgrom, ML
    Goggins, WC
    Murdock, P
    Pescovitz, MD
    TRANSPLANTATION, 2004, 77 (08) : 1304 - 1306
  • [10] Hypotension after reperfusion in liver transplantation: histidine-tryptophan-ketoglutarate versus University of Wisconsin solution
    Ghafaripour, S.
    Sahmeddini, M. A.
    Lahsaee, S. M.
    Khosravi, M. B.
    Sattari, H.
    Nikeghbalian, S.
    Shokrizadeh, S.
    Malekhosseine, S. A.
    PROGRESS IN TRANSPLANTATION, 2010, 20 (03) : 256 - 261